Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement

Blood Res. 2023 Dec 31;58(4):242-245. doi: 10.5045/br.2023.2023194.

Authors

Seo Yoon Jang¹, Ja Min Byun¹, Sung-Soo Yoon¹, Jin Chul Paeng², Seung-Pyo Lee¹, Youngil Koh¹

Affiliations

¹ Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
² Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Publication types

Letter

Grants and funding

Acknowledgments The study drug lenalidomide was supported by BMS.